Portugal sees jump in COVID-19 cases, eyes restrictions


File - A woman wearing a face mask uses her cellphone in a subway train in Lisbon, on Oct. 22, 2021. Portugal has inoculated 86% of the country against COVID-19, but its prime minister is warning that a recent surge in infections across Europe compels it to consider taking precautionary measures. The government has convened a meeting of health experts on Friday to assess what measures may be required. (AP Photo/Armando Franca, File)

LISBON, Portugal (AP) — Portugal on Wednesday reported its highest number of new daily COVID-19 infections since July amid a surge in cases across Europe, though hospitalizations are rising more slowly in the country where 86% of people are vaccinated.

The Portuguese government is due to announce on Thursday what new pandemic restrictions it is introducing, seven weeks after scrapping almost all of them because of the high vaccination rate and perceived lower threat from the coronavirus.

The General Directorate for Health officially reported 3,773 new cases Wednesday, with 681 in hospitals, 105 in intensive care units and 17 deaths. The number of patients requiring hospitalization was the highest since September.

On Nov. 1, Portugal reported fewer than 500 new infections, 360 people hospitalized, 60 in intensive care and five deaths. Those numbers were similar to those a month earlier.

The rise reflects a broader surge in Europe, with some countries severely tightening restrictions, but the government has said it doesn’t foresee the immediate need for a lockdown.

The junior minister for health, António Lacerda Sales, said booster shots will begin next week for people who had the single-dose Johnson & Johnson shot — around 250,000 people.

Authorities are considering whether to begin inoculating children between 5 and 11 years old.

___

Follow all AP stories on the pandemic at https://apnews.com/hub/coronavirus-pandemic

Should you invest $1,000 in Johnson & Johnson right now?

Before you consider Johnson & Johnson, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Johnson & Johnson wasn't on the list.

While Johnson & Johnson currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Johnson & Johnson (JNJ)
4.9063 of 5 stars
$148.53-0.7%3.20%9.26Hold$175.86
Compare These Stocks  Add These Stocks to My Watchlist 


Featured Articles and Offers

Johnson & Johnson's Dip is a Strategic Buy Point for Investors

Johnson & Johnson's Dip is a Strategic Buy Point for Investors

JNJ shares hit a low, trading near $145 at under 14X earnings. With a high dividend yield, it's poised for a rebound.

Search Headlines: